Beth Israel Deaconess Medical Center (BIDMC)'s discovery of a second B-cell attachment receptor for Epstein-Barr virus (EBV) sheds more light on the workings of the widespread infection which affects more than 90 percent of the global population. The new findings, which currently appear on-line in iCell Reports/i, reinforce current directions being taken in the development of a vaccine to guard against EBV, and raise important new questions regarding the virus's ...Saturday, 23 February 2013
Scientists Discover Second B-Cell Attachment Receptor for Epstein-Barr Virus
Beth Israel Deaconess Medical Center (BIDMC)'s discovery of a second B-cell attachment receptor for Epstein-Barr virus (EBV) sheds more light on the workings of the widespread infection which affects more than 90 percent of the global population. The new findings, which currently appear on-line in iCell Reports/i, reinforce current directions being taken in the development of a vaccine to guard against EBV, and raise important new questions regarding the virus's ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment